Edison Scientific raises $70M led by Triatomic Capital, Spark Capital, and other investors

Science is too slow.

At Edison, the company is integrating AI Scientists into the full stack of research, from basic discovery to clinical trials. The goal is cures for all diseases by mid-century.

Edison has raised a $70M seed round to get started. Triatomic Capital, Spark Capital, and a major U.S. institutional biotech investor lead the round. The company is also joined by existing investors Pillar VC and Susa Ventures—two exceptional early-stage funds that backed Edison at founding—along with Striker Venture Partners, Hawktail VC, Olive VC, and a host of exceptional angels that includes famous AI researchers, the CEOs of multiple frontier AI labs, and leadership from major biotech and pharma companies.

Join them…
Edison needs cracked software engineers who want to work on finding cures rather than selling ads and generating slop. If someone is reading this, they are probably a candidate.

The company needs brilliant AI researchers who want to figure out how AI will accelerate real-world science. Edison also needs scientists and researchers with deep expertise in biology, biotech, and pharma who want to integrate AI deeply into scientific workflows—from ideation to experimentation—and to define how success or failure should be measured.

Edison is also looking for extraordinarily talented generalist operators across business development, sales, product management, and partnerships who can focus on getting these tools into the hands of pharmaceutical companies.

If any of these roles sound like a fit, apply here:
edisonscientific.com/careers

Expanding access to the platform
Edison’s goal is to accelerate science writ large. To that end, the company will continue to give academics and students 650 credits per month indefinitely. There is no promise this will last forever, but the intention is to keep it going as long as possible. Kosmos will still cost 200 credits, and the other agents (Analysis, Literature, etc.) will cost 1 or 2 credits. All paid users will have free access to regular agents—such as the Analysis and Literature agents—via the UI. API access will remain paid, and users without a paid subscription will continue to receive 10 credits per month for those agents. The $200/month subscription for 650 credits per month is staying in place for now, but may be phased out at the next major product update.

In line with accelerating science, Edison is also releasing a significant update to PaperQA today, its flagship open-source literature agent, as part of its commitment to open science. In the short run, users should expect significant improvements to Kosmos, including automatic data access, the ability to steer its exploration, and the ability to converse directly with its world model. In the long run, Edison expects exponential growth in scientific discovery in biology and beyond.

Try Kosmos on the platform:
platform.edisonscientific.com/login

source[Edison Scientific]